Bioactive mesopore-glass microspheres with controllable protein-delivery properties by biomimetic surface modification by Wu, Chengtie et al.
 1
 
 
 
Bioactive mesopore-glass microspheres with controllable protein-delivery 
properties by biomimetic surface modification 
 
 
 
Chengtie Wu,1 Yufeng Zhang,1,2 Xuebin Ke,3 Yuxuan Xie,4 Huaiyong Zhu,3 Ross Crawford,1 Yin Xiao1 
 
 
 
 
1. Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, 
Queensland 4059, Australia. 2. Ministry Education Key Laboratory for Oral Biomedical 
Engineering, School of Stormatology, Wuhan University, Wuhan 430079, PR China. 3. School of 
Physical and Chemical Sciences, Queensland University of Technology, Brisbane 4001, Australia. 4. 
EMU, the University of Sydney, Sydney, 2006, Australia. 
 
 
 
 
                                                        
 Correspond author: yin.xiao@qut.edu.au (Y. Xiao) 
Tel: 61-7-31386240; Fax: 61-7-31386030 
 2
Abstract 
Microsphere systems with the ideal properties for bone regeneration need to be bioactive, and at the 
same time possess the capacity for controlled protein/drug-delivery; however, the current crop of 
microsphere system fails to fulfill these properties. The aim of this study was to develop a novel 
protein-delivery system of bioactive mesoporous glass (MBG) microspheres by a biomimetic 
method through controlling the density of apatite on the surface of microspheres, for potential bone 
tissue regeneration. MBG microspheres were prepared by using the method of alginate 
cross-linking with Ca2+ ions. The cellular bioactivity of MBG microspheres was evaluated by 
investigating the proliferation and attachment of bone marrow stromal cell (BMSC). The loading 
efficiency and release kinetics of bovine serum albumin (BSA) on MBG microspheres were 
investigated after coprecipitating with biomimetic apatite in simulated body fluids (SBF). The 
results showed that MBG microspheres supported BMSC attachment and the Si containing ionic 
products from MBG microspheres stimulated BMSCs proliferation. The density of apatite on MBG 
microspheres increased with the length of soaking time in SBF. BSA-loading efficiency of MBG 
was significantly enhanced by co-precipitating with apatite. Furthermore, the loading efficiency and 
release kinetics of BSA could be controlled by controlling the density of apatite formed on MBG 
microspheres. Our results suggest that MBG microspheres are a promising protein-delivery system 
as a filling material for bone defect healing and regeneration. 
Key words: Bioactive mesopore-glass microspheres; Controllable protein delivery; Apatite; Cell 
proliferation 
 
INTRODUCTION 
The use of bioactive microspheres as protein/drug carriers and bone filling materials has received 
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much attention in recent years.1,2 Compared to traditional macroporous block scaffolds, the main 
advantage of microspheres is that they not only possess better drug-delivering properties, but also 
the ability to fill bone defects of irregular and complex shapes and sizes. The space between the 
microspheres is crucial for effective and functional bone regeneration 3-5 as they allow for both bone 
and vascular ingrowths. However, for microspheres to be applied as bone fillers in bone-tissue 
regeneration there are three major issues that needs to be resolved: (i) controllability of drug-release; 
(ii) bioactivity; and (iii) degradability. Currently available microspheres are made of ceramics, 
polymers or their composites. Polymers microspheres, such as poly(lactic-co-glycolic acid) (PLGA) 
and poly(hydroxybutyrate-polyhydroxyvalerate) (PHBV), are resorbable but their bioactivity is less 
than optimal. 2,6 On the other hand, ceramic microspheres, such as hydroxyaptite (HAp) ceramics 
with large size (several hundred micrometer), are bioactive, but lack controllable protein/drug 
ability and adequate degradation.1,7-10 Although nano-sized spheres have been developed for drug 
delivery, their small sizes compromise their use in cell-based therapy for bone tissue engineering. 
Their nanometer sizes result in an inadequate space for tissue and vascular ingrowth and they are 
also too small to carry bone forming cells. Therefore, it is necessary to develop a new class of larger 
sized bioactive microspheres (hundreds of micrometer) with controlled protein/drug-delivery 
properties and improved bioactivity and degradation rates.  
Bioactive glass is a typical bioactive inorganic material in that it can bond with host bone tissue by 
forming a biologically active bone-like apatite layer after implantation.11 Compared to other 
bioactive ceramics, such as HAp and β-tricalcium phosphate (β-TCP), bioactive glass possesses 
greatly improved bioactivity and degradation properties.11 A new class of bioactive glass was 
recently developed with a highly ordered mesopore channel structure with pore sizes ranging from 2 
to 50 nm, referred to as bioactive mesoporous glass (MBG).12,13 A significant feature of MBG is 
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that it possesses a significantly improved specific surface area and pore volume, which gives it 
superior bioactivity compared to non-mesoporous bioactive glass (NBG).12,14 Recently, we have 
shown that the incorporation of MBG powders into PLGA polymers significantly enhanced the 
bioactivity, degradation rate and drug-delivery properties of PLGA.15 In addition, studies by other 
investigators have shown that MBG powders possess significantly improved drug loading ability as 
a result of their uniquely ordered channels and high specific surface area, when compared to NBG 
powders.16,17 These findings suggest that MBG micropsheres have far greater potential for bioactive 
bone regeneration and drug delivery than the more traditional materials. However, to the best of our 
knowledge, most of the present studies of MBGs are focused on MBG powders, which severely 
limit their further application, in spite of their excellent bioactivity and degradation. It is therefore 
reasonable to hypothesize that MBG microsphere with larger size and controllable protein delivery 
will be a more satisfactory bone filling material.  
Previous studies have shown that biologically active molecules, such as growth factors, can be 
co-precipitated with CaP crystals on the surface of metal implants without compromising the 
bioactivity of osteogenic agents due to the mild conditions employed during the coating process 18. 
It has been reported that the CaP coatings incorporated with bioactive molecules can substantially 
improve the bioactivity and enhance the osteogenic activity of the metal implant.18-20 A recent study 
incorporated proteins into the CaP coatings on polymers to enhance the binding ability of the 
proteins.21 However, few, if any, studies have investigated the controlled loading and release of 
proteins/drugs from biomimetic apatite. Since it is known that MBG has excellent apatite-forming 
ability in simulated body fluid (SBF), our hypothesis was that by controlling the soaking time of 
MBG in SBF, the density of apatite on the MBG microspheres could be controlled, thereby 
controlling both protein loading and release. The aim of this study was to prepare and characterize 
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MBG microspheres, and further to control the density of apatite on the microspheres and hence 
protein loading and release for potential bone tissue regeneration application. 
 
MATERIALS AND METHODS 
Preparation and characterization of MBG microspheres 
MBG powders (molar ratio: Si/Ca/P = 80/15/5) were synthesized according to our previous 
publication.22 In a typical synthesis, 4.0 g of P123, 6.7 g of tetraethyl orthosilicate (TEOS, 98%, 
Acros), 1.4 g of Ca(NO3)2.4H2O, 0.73 g of triethyl phosphate (TEP,99.8%, Sigma–Aldrich) and 1.0 g 
of 0.5 M HCl were dissolved in 60 g of ethanol (Si/Ca/P¼ 80:15:5, molar ratio) and stirred at room 
temperature for 1 day. The resulting sol was introduced into a Petri dish for an evaporation-induced 
self-assembly process, and then the dry gel was calcined at 700 ºC for 5 h to obtain MBG powders.  
The obtained MBG powders were ground and sieved to 230 meshes for the preparation of MBG 
microspheres by using a method of alginate crosslinking with CaCl2 solutions. Typically, 3.125 
gram of MBG powder was added into 40 mL water solution and stirred for 30 min to form slurry. 
Alginate powder was then dissolved in water to form the alginate solution with a concentration 3% 
(w/v). The alginate solution was added to MBG slurry and stirred for 1 hr and ultra-sonicating for 5 
min to form homogenous mixtures. The mixture was extruded drop-wise into a 0.1 M CaCl2 
crosslinking solution through a 0.80 mm hypodermic needle, forming spherical particles, which 
were hardened by 30 min incubation in the crosslinking solution. The wet microspheres were 
filtered, dried at 50 ºC and calcined at 680 ºC for 3 hr with a heating rate of 1 ºC/min to obtain the 
MBG microspheres. The phase composition, surface morphology, element composition and inner 
microstructure of the calcined MBG microspheres were analyzed by wide-angle X-ray diffraction 
(XRD), small-angle XRD, Transmission electron microscopy (TEM), optical microscopy, scanning 
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electron microscopy (SEM) and energy-dispersive spectrometer (EDS). The surface area, the pore 
size distribution and the pore volume were tested using N2 adsorption-desorption isotherms. The 
open porosity of MBG microspheres was tested using Archimedean method. 
 
The effect of ionic products from MBG microspheres on BMSC proliferation 
The bone marrow samples (n= 5) for isolation of human bone mesenchymal stem cells (BMSCs) 
were obtained Prince Charles Hospital, Brisbane. Ethics clearance for this project was approved by 
the Human Ethics Committee at Queensland University of Technology. BMSC culture was carried 
out according to our previous publications.23 The extracts of MBG microspheres were diluted in 
culture medium according to International Standard Organization (ISO/EN 10993-5) 24 by adding 
MBG microspheres to serum free α-MEM culture medium at a ratio of 200 mg/mL (MBG to 
medium). After incubating at 37ºC for 24 hr, the mixture was filtered and the supernatant was 
collected. Serial dilutions of extracts (100, 50, 25, 12.5 and 6.25 mg/ml) were prepared using 
serum-free α-MEM medium (without L glutamine or ascorbic acid). The diluted extracts were 
filtered using 0.22 μm filter and used in subsequent BMSC cell culture experiments. The ionic 
concentration of the diluted extracts was measured by atomic emission spectrometer (Table 1). 
BMSCs were seeded at a density of 3×103 cells/well into 96-well plate and incubated for 24 hr. The 
culture medium was then removed and replaced by 50 μL of α-MEM medium supplemented with 
10% FCS and 50 μL of diluted extracts. Culture medium supplemented with 10% FCS without 
addition of diluted extracts was used as a blank control (Blank), and 50 μL solution of 0.2% Triton 
X-100 and 50μL of α-MEM medium supplemented with 10% FCS was used as a negative control 
(Ctr-). Cells were then incubated at 37ºC in 5% CO2 for 1, 3 and 7 days. At these time points 100 
μL of 0.5 mg/mL MTS (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution 
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was added in each well and incubated for 4 hr at 37ºC. The reaction was terminated by the addition 
of dimethyl sulfoxide. The absorbance of the formazan was read at 495 nm using an Enzyme-linked 
immunosorbent assay (ELISA) plate reader. This assay is based upon the conversion of MTS to 
formazen. Results were expressed as absorbance reading from each well minus the optical density 
value of blank wells. 
 
BMSCs attachment on MBG microspheres 
MBG microspheres were transferred into 96 wells. After pre-wetted with serum free culture 
medium overnight, 100 µL cell suspensions containing 5×105 BMSCs were seeded into each well. 
After 72 hr the cells were fixed in 4% paraformaldehyde for 20 min and washed in PBS, 
permeabilized in 0.5% Triton for 15 min, and washed again in PBS. After washing, filters were 
incubated for 1 hr at room temperature with Alexa FluorTM 568 phalloidin (1:50 dilution; Invitrogen 
A12380) diluted in 0.1% PBS/BSA, washed with PBS at RT for 3 x 5 min, then labeled with 
4,6-diamidino-2-phenylindole (DAPI; 1 µg/ml; Sigma-Aldrich, St. Louis, MO) for 30min. DAPI is 
a nuclear fluorescent stain. Samples were washed with PBS and examined with a Leica SP5 
confocal microscope (Mannheim Germany).    
 
Preparation and characterization of BSA-loaded MBG microspheres with apatite layer  
Simulated body fluids (SBF) were prepared according to Kokubo.25 Then, 100 mg of BSA (Sigma) 
was dissolved in 50 mL SBF solution. 0.075 g of MBG microspheres were immersed in the 
BSA/SBF solution and kept under static conditions at 37 ºC for 1, 3 and 7 days. The bovine serum 
albumin (BSA) is commonly used in several studies to simulate human albumin, due to the 
structure homology of two proteins.26 The microspheres were labeled MBG-SBF-1d, MBG-SBF-3d 
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and MBG-SBF-7d according to the length of time soaking in the SBF solution. After soaking in 
SBF the BSA-loaded microspheres were dried at 60ºC for 24 hr. Apatite formed on the surface of 
MBG microspheres was analyzed using SEM, EDS, Wide-angle XRD and Fourier transform 
infrared spectroscopy (FTIR). For controls, BSA-loaded MBG microspheres without apatite layer 
were prepared by soaking 0.075g of MBG microspheres in 50mL BSA water solution (2mg/ml) for 
24 hr. 
 
BSA loading and release kinetics from MBG microspheres with apatite layer 
  To determine the loading ability of BSA on MBG, MBG-SBF-1d, MBG-SBF-3d and 
MBG-SBF-7d microspheres, the weight loss profiles of the four dried BSA-loaded MBG 
microspheres species were analyzed by thermogravimetric analysis (TGA) from room temperature 
to 800 ºC. BSA loading efficiency (LE) was calculated using the equation: LE = (mass of BSA/mass 
of MBG microspheres) * 100%, according to weight loss profile at the range of 200-800ºC.  
For evaluation of the effect of apatite layer on the BSA release, 0.045g of BSA-loaded MBG 
microspheres were placed into 1 mL PBS (pH = 7.4) at 37 ºC for 1, 3, 6h, 1, 3, 7, 14, 21 and 28 
days. At each time point, 1 mL PBS solution was taken out to test the concentration of released BSA 
by UV/VIS at the wavelength of 280nm and 1 mL fresh PBS solution was added to the plastic tubes 
containing the microspheres. Three samples for each kind of microspheres were taken for mean and 
standard deviation calculation. 
Statistical analysis 
The data was expressed as means ± standard deviation (SD) for all experiments and were analyzed 
using one-way ANOVA with a post hoc test in ORIGIN statistic software, where p-value < 0.05 
was considered statistically significant. 
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RESULTS AND DISCUSSION 
Characterization of MBG microspheres 
The resulting MBG microspheres were approximately 1 mm in diameter with uniform size 
distribution (Fig. 1a and b), and composed of MBG microparticles with a loose microstructure (Fig. 
1c). Both the surface and in the interior of the microspheres contain numerous micropores (Fig. 1c 
and d). EDS analysis of the microspheres revealed an abundance of Ca, Si and P elements (Fig. 1c). 
Small angle XRD results showed that the microspheres had an apparent differential peak at 2θ = 
1.25o (Fig. 2a), which indicates that the MBG has mesopore walls with a hexagonal structure. The 
open porosity of the obtained MBG microspheres is about 37%. TEM analysis showed that MBG 
microspheres possessed a highly ordered nano-mesopore channel structure and that the pore 
diameter was approximately 5 nm across (Fig. 2b). The results for N2 adsorption-desorption 
analysis have shown the type of IV isotherm, a typical characteristic of a mesoporous structure (Fig. 
2c). MBG microspheres presented a relative narrow pore size distribution, and the peak pore size is 
around 5nm (Fig. 2c), which is consistent with the result obtained by TEM analysis. The pore size 
distribution is mainly in the range of 3nm to 11nm, and the BET surface area of MBG is 336m2/g. 
As after microspheres were sintered, we then crashed microspheres to be powders, and then we 
found that the size of nanopores in the powders is 5nm. Therefore, the nanopore is within the 
microspheres. These results confirmed that large-sized MBG microspheres are obtainable by the 
described method, and that alginate crosslinking with CaCl2 solution, followed by heat treatment 
does not alter the highly ordered channel structure of MBG. This indicates that the microspheres are 
capable of maintaining the inherent characteristics of mesopore materials, such as high specific 
surface area and high bioactivity.16,22 A further advantage of this production method is that the MBG 
 10
microspheres have a relatively large size of 1 mm. This provides sufficient surface area for bone 
cell attachment and growth as well as large interstitial space (room) between the microspheres for 
both tissue and vascular ingrowth, both essential properties for effective and functional bone 
regeneration.3,4 Furthermore, the loose structure and high micropore content inside the MBG 
microspheres provide adequate space for drug/protein loading. 
 
BMSCs response to MBG microspheres 
The ionic products of MBG microspheres significantly stimulated BMSC proliferation compared to 
the blank controls after 3 days in culture (Fig. 3). Calcium and silicon ions can stimulate osteoblast 
proliferation, differentiation and osteogenic gene expression 27-30 and our data showed that Si ion 
concentrations in MBG extracts were significantly higher than those of the controls, whereas Ca ion 
concentrations were similar between MBG extract and the controls (Table 1). It is therefore 
plausible that Si ions from the MBG microspheres are the main factor responsible for stimulating 
cell proliferation. However, this stimulatory effect depends on a certain concentration range. In a 
specific concentration range of Si ions, although all Si containing MBG extracts have enhanced cell 
proliferation compared to blank control without Si ions, the cell proliferation for these Si containing 
MBG extracts has no obvious difference. According to published assessment criteria; this 
stimulatory effect is regarded as one of the evaluation criterions for the bioactivity of 
biomaterials.27,31 Our results indicate that the MBG microspheres have the potential to stimulate 
bone tissue growth by releasing bioactive Si ions and are therefore promising materials for bone 
repair applications. Indeed, cell experiments demonstrated that MBG microspheres supported 
BMSC attachment and growth (Fig. 4), indicating that the microspheres are suitable as cell carrier 
for potential tissue engineering applications. 
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 Characterization of apatite formation on MBG microspheres as a function of soaking time 
Controllable apatite deposition on the MBG microspheres was achieved by soaking the spheres in 
SBF for various lengths of time. SEM analysis showed that apatite particles deposited on the 
microsphere surface increased as a function of soaking time (Fig. 5) and the spheres appeared to 
maintain their rounded morphology (Fig. 5a, b and c). At day 1, only a limited number of apatite 
particles were seen on the microsphere surface (Fig. 5d). The ratio of Ca/P was 2.52 (Fig. 5g), 
which was less than that prior to soaking at 3.06. A loose apatite layer was apparent after 3 days of 
soaking and there were discernible peaks of Ca and P elements (Fig. 5e and h). After 7 days, a dense 
apatite layer, composed of apatite particles with an obvious crystalline morphology, had formed. Ca  
and P elements were found only in the deposited apatite (Fig. 5i). Wide angle XRD patterns showed 
that with increased soaking time, the intensity of apatite characteristic peaks (standard card No 
JCPD:24-0033) increased and that wollastonite (CaSiO3) peaks decreased (Fig. 6). By day 7, only 
apatite peaks were seen and the wollastonite peaks had entirely disappeared (Fig. 6). FTIR analysis 
showed that prior to soaking in SBF the MBG microspheres had a overlap peak of PO43- at the wave 
number of 1030 cm-1 and Si-O at the wave number of 980 cm-1 (Fig. 7). Wave number 566 cm-1 
revealed a small PO43- peak from microspheres that had soaked in SBF for 1 and 3 days, the result 
of new apatite formation. At day 7, the intensity of all the PO43- peaks at the wave number both 566 
and 1030 cm-1 increased, and CO32- characteristic peaks at the wave number of 872 cm-1were also 
detectable (Fig.7), which indicated that the apatite was formed was carbonate-apatite.32,33 The 
mechanism of apatite formation on MBG is due to silicate dissolution and re-deposition of Ca and P 
ions, as well as the effect of specific mesopore structure.12,16 One of the principal aims of the 
present study was to demonstrate controlled protein loading and release by controlling the density 
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of the apatite formed on the surface of MBG microspheres. Our results showed that as SBF soaking 
time increased, there was an increased apatite deposition, with a more pronounced crystalline 
structure, on the MBG microsphere surface, a clear indication that the apatite forming ability of 
MBG microspheres is a function of the soaking time in SBF. 
 
Bovine serum albumin (BSA) loading efficiency of MBG microsphere with a function of 
apatite formation 
TGA analysis showed there was an obvious weight loss for all the microspheres with increased 
temperature (Fig. 8). From room temperature to 200 ºC the weight loss was mainly due to the loss 
of water, whereas from 200 to 800 ºC the weight loss was mainly due to the burning out of the BSA. 
The BSA loading efficiency was calculated according to (weight loss)% in the 200-800ºC range. 
Table 2 shows the loading efficiency of BSA on MBG microspheres at 0, 1, 3 and 7 days soaking in 
SBF. Loading efficiencies of BSA improved significantly by co-precipitation with apatite compared 
to MBG microspheres without apatite, reaching 16.51% at day 7, more than 4 times than that of 
pure MBG microspheres. These results suggest that dissolving BSA in SBF solution, and 
co-precipitating with apatite onto MBG microspheres, is an efficient way to enhance the loading 
efficiency of BSA. Figure 10 shows a schematic model of how BSA is thought to be loaded into the 
MBG microspheres with respect to the incubation time in SBF. At all four time points, the BSA is 
trapped in the inner MBG microspheres within the loose structure and micropores, and binds with 
hydroxyl groups on the surface of the MBG particles by hydrogen bonds 16. As the apatite accretes 
on the microspheres, the BSA binds to the MBG particles, as well as the apatite particles on the 
microspheres, by the chemical groups OH-, PO43- and CO32, thereby enhancing the BSA loading 
ability. Our results showed that the loading capacity of BSA increased with increased soaking time 
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in SBF. The most likely explanation for this is that the increased density of apatite particles (shown 
in the section 2.3) allows binding of more BSA molecules; the BSA loading is therefore effectively 
controlled by the soaking time in the SBF solution. It is likely that this method can be used for 
controlled protein loading with other bioactive ceramics materials as well.  
 
Controllable release kinetics of BSA from MBG microspheres 
The chief finding from this study was that BSA release kinetics from MBG microspheres can be 
controlled by the accretion of an apatite layer on the surface of MBG microspheres. Figure 9 shows 
that MBG microspheres without an apatite layer had a burst release of BSA at the early stage, 
whereas MBG microspheres with an apatite layer had slower release kinetics. As the soaking time 
in SBF increased, there was a corresponding decrease in the BSA release kinetics (Fig.9). We also 
demonstrated a positive correlation between the length of time the microspheres were incubated in 
SBF and the amount of apatite formation, which to us suggested that the apatite itself played a role 
in the rate of BSA release. There are two likely explanations for this phenomenon: (i) that the 
apatite particles on the microsphere surface have greater specific surface area and therefore more 
chemical groups with which to bond BSA through molecular interactions, thereby decreasing the 
release rate of BSA; or (ii) that a denser apatite layer forms on the microsphere surface with 
increased soaking time in SBF, which may then retard the release of BSA from within the 
microspheres. The morphology of MBG microspheres after 28 days’ release in PBS has been 
observed and shown in Figure 10. It is obvious that a layer of nano-apatite particles formed on the 
surface of MBG microspheres after release of BSA in PBS. Figure 11 shows a schematic model of 
how BSA capture is thought to accumulate as a function soaking time in SBF, and then 
subsequently released from the microspheres. Our results showed that the accumulative release of 
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BSA from the MBG-SBF-7d microspheres after 28 days in PBS, was no more than 8%, suggesting 
that most of BSA was trapped in, or by, the apatite layer. BSA can be incorporated into the lattice 
structure of the Ca-P minerals through the electrostatic interactions between BSA and the crystals34, 
making it reasonable to speculate that the BSA was chemically bound to the apatite crystals rather 
than simply being adsorbed to the surface of the crystals. From our study, it is speculated that parts 
of BSA may embed in the internal pores (nano-pore channel) of MBG, which results in a sustained 
release even after 28 days of release, and the total release of BSA in pure MBG microspheres is no 
more than 40%. However, the apatite layer on the surface of MBG microspheres plays a key role to 
decrease the burst release of BSA, which indicates that BSA may form strong chemical bonding 
with apatite particles on the surface of MBG microspheres. Furthermore, the release kinetics of 
BSA at the early stage is much higher than that in the late stage, which indicates that the release 
behaviour of BSA in MBG system at early stage is mainly controlled by a diffusing way. However, 
the release kinetics in late stage is influenced by the degradation of the delivery system and 
re-precipitation of apatite particles (Figure 10). Our results indicate that controlling the density of 
apatite by varying the soaking time in SBF is a facile, yet useful way to control protein release.  
Other investigators have confirmed that bone-like apatite layers possess a capability to enhance 
osteoblastic activity,35,36 and previous work by our group has shown that apatite layers on the 
surface of bioactive ceramic bredigite (Ca7MgSi4O16) scaffolds enhanced osteoblast spreading, 
proliferation and differentiation,37 suggesting that the bone-like apatite layer formed on MBG 
microspheres may in fact enhance their cellular activity. In addition to showing that protein loading 
and release can be controlled by the apatite layer on MBG microspheres, we also showed that the Si 
containing ionic products from MBG microspheres can stimulate BMSCs proliferation. Therefore, 
compared with current microspheres, such as polymer and HAp microspheres, as bone filler 
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materials, the significant advantages of current MBG microspheres are that 1) they have a more 
controllable protein-delivery ability; 2) they have improved bioactivity (apatite-formation ability in 
SBF); 3) They are able to stimulate bone cell proliferation by releasing bioactive Si ions. Together 
these data lend support to MBG microspheres being a promising material for cell growth and 
controllable delivery of growth factor/drug, with a great potential for bone tissue regeneration 
application. 
 
CONCLUSIONS 
MBG microspheres with uniform morphology, large size and loose microstructure were 
successfully prepared by the method of combining alginate cross-linking CaCl2 with heat treatment. 
These microspheres supported BMSC attachment and the Si containing ionic products from MBG 
microspheres stimulated cell proliferation. The BSA-loading efficiency of MBG was significantly 
enhanced by co-precipitating with apatite, and it appears that both loading efficiency and release 
kinetics of BSA can be controlled by controlling the density of the apatite formed on MBG 
microspheres by varying the soaking time in SBF. Altering the soaking time of bioactive MBG 
microspheres in SBF is therefore a facile and useful way to control the apatite-formation ability, and 
by so doing, to control BSA loading and release. These results suggest that MBG microspheres are 
a promising filling material for applications in bone regeneration by virtue of their controllable 
protein-delivery, as well as excellent bioactivity and degradation properties. 
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Figure captions 
Figure 1. Optical pictures for MBG microsphere with uniform size (a), SEM pictures for single 
microsphere (b) and surface microstructures (c), and inner microstructure (d). EDS analysis shows 
that the ratio of Ca/P is 3.06 in (c). 
Figure 2. Small angle XRD (a), TEM (b), and N2 adsorption-desorption isotherms and the 
corresponding pore size distributions (inset) (c) analysis for MBG microspheres. 
Figure 3. The effect of ionic products from MBG microspheres on bone marrow stromal cell 
(BMSC) viability. The number of cell attachment at day 1 was similar in different MBG extract 
concentrations compared with the control and tissue culture plate. However, cell number was 
significantly increased in all groups containing MBG extract after three days in culture compared 
with the cell number in tissue culture plate, which indicated an enhanced effect of MBG extract on 
cell proliferation. The corresponding Ca and Si ion concentrations at different extract concentration 
were listed in Table 1. 
Figure 4. BMSC attachment on MBG microspheres after culturing for 3 days. Fluorescent 
phalloidin (red) marking actin filaments in BMSCs, and nuclei with DAPI (blue). 
Figure 5. SEM and EDS analysis of MBG microspheres soaked in SBF for 1 d (a), (d) and (g); 3d 
(b), (e) and (h); 7d (c), (f) and (i).  The corresponding ratios of Ca/P are 2.52, 1.73 and 1.91. (d), (e) 
and (f) are higher magnification SEM. 
Figure 6. Wide angle XRD analysis of MBG microspheres after soaking in SBF for 1, 3 and 7 days. 
Figure 7. FTIR analysis of MBG microspheres after soaking in SBF for 1, 3 and 7 days. 
Figure 8. TGA analysis of MBG microspheres loaded with BSA by SBF soaking for different time 
periods. 
Figure 9. BSA release kinetics (accumulative release %) from MBG microspheres treated by SBF in 
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PBS at pH 7.4 for 28 days (a).  Figure (b) is listed to show the difference of BSA release in the 
early stage (3 days). 
Figure 10. Surface morphology of MBG microspheres after releasing of BSA in PBS for 28 days. 
Figure 11. Schematic illustrations of BSA loading and release in four MBG microspheres. The left 
column is BSA loading and the right column is BSA release. With the increase of soaking time in 
SBF, more and more apatite particles deposited on the surface of MBG microspheres, which 
enhanced BSA loading efficiency and decreased BSA release kinetics. 
 
